Putting propylthiouracil in perspective.
Cooper
David S
DS
Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, 1830 East Monument Street, Suite 333, Baltimore, Maryland 21287, USA. dscooper@jhmi.edu
Rivkees
Scott A
SA
D000328:Adult; D013956:Antithyroid Agents / Q000009:adverse effects / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy* / Q000453:epidemiology; D015994:Incidence; D008107:Liver Diseases / Q000150:complications / Q000453:epidemiology / Q000628:therapy; D016031:Liver Transplantation / Q000706:statistics & numerical data; D008297:Male; D008713:Methimazole / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011441:Propylthiouracil / Q000009:adverse effects* / Q000627:therapeutic use*; D014481:United States / Q000453:epidemiology
D013956:Antithyroid Agents; D008713:Methimazole; D011441:Propylthiouracil